IntelliCyt Corporation

IntelliCyt Corporation is the market leader in suspension-cell analysis platforms for immunology and immuno-oncology profiling, antibody discovery, and screening of immune targets in drug discovery and life science research.

IntelliCyt’s iQue Screener can rapidly and cost effectively profile physiologically-relevant model systems for phenotypic endpoints using multiplexed cell and/or bead-based assays.

Our easy-to-use instruments, software, and reagent kits are optimized to work together and designed to conserve precious samples, use less reagent, and minimize time-to-answer. Our high-content solution offers fast and rich per-cell information that delivers the deep insight that complex biology demands.

The top 10 pharmaceutical companies and premier biotechnology and academic institutes, including leaders in immuno-oncology, have made the iQue Screener platform an integral part of their daily research.

Whitepaper: Addressing the challenges in biologics discovery with advanced flow cytometry

Article: Immuno-oncology: Pushing the frontier of discovery through advanced high throughput flow cytometry

Application note: A kinase inhibitor phenotypic screen using a multiplex T Cell activation assay

Application note: A novel solution to expedite antibody discovery

Application note: A novel way to expedite antibody discovery

Whitepaper: Advancing therapeutic antibody discovery with multiplexed screening

Application note: Multiplexed detection of mouse cytokines using QBeads and the iQue Screener

Application note: A high-throughput, radioactivity-free assay for cell-mediated cytotoxicity

Application note: Application of MultiCyt QBeads for high throughput cytokine profiling in human peripheral blood mononuclear cells

Training and development in flow cytometry and other core technologies

Expert view: Opportunities in flow cytometry

Application Notes supplement 2018

Expert view: Challenges in flow cytometry

Flow Cytometry In-Depth Focus 2018

Expert view: Multiplexed screens in biologics discovery

Antibodies In-Depth Focus 2018

Expert view: Reviewing the biggest innovations in antibody screening

Screening In-Depth Focus 2018

High throughput flow cytometry for multifactorial evaluation of novel therapeutic candidates using an innovative in vitro immunooncology screening platform

Expert view: Addressing the big challenges in drug screening

Screening In-Depth Focus 2017

Screening In-Depth Focus 2017

Screening In-Depth Focus 2016

Under the microscope with Joseph Zock, IntelliCyt Corporation

True screening for immunology: transforming science with a practical tool for large-scale discovery

IntelliCyt launches novel assay system to accelerate cell line development

High throughput flow cytometry for multifactorial evaluation of novel therapeutic candidates using an innovative In vitro immuno-oncology screening platform

Advancing the discovery of immunotherapeutics with large scale multiplexed experiments

Evaluating immunotherapeutic approaches with large scale functional assays for immuno-oncology

Use of IntelliCyt’s iQue Screener for high-throughput screening of small molecules, CRISPRs and stem cells

Identification of antibodies against difficult targets

Immunology Screening on the iQue Screener